Literature DB >> 23297790

Endophenotypes in psychopathology research: where do we stand?

Gregory A Miller1, Brigitte Rockstroh.   

Abstract

Endophenotypes for psychopathology have been conceived as latent, unobserved, but measureable manifestations of phenomena that causally connect genetic liability to clinical disorder. Several decades of research have led to refinement of the construct and identification of some candidate endophenotypes, but rather limited progress on finding the genes involved or the mechanisms by which endophenotypes are driven by genetic and environmental factors and in turn drive psychopathology. Currently promising avenues for research involve development of transdiagnostic concepts not limited to traditional diagnostic categories, measures of endophenotypic and manifest psychopathology that have higher validity than those categories, and methods for modeling complex relationships among diverse contributors to etiology. With more grounding in animal neuroscience and other aspects of basic biological and psychological science, exemplified in the Research Domain Criteria initiative, there is every reason to anticipate that the endophenotype concept will grow more central in the psychopathology literature.

Mesh:

Year:  2013        PMID: 23297790     DOI: 10.1146/annurev-clinpsy-050212-185540

Source DB:  PubMed          Journal:  Annu Rev Clin Psychol        ISSN: 1548-5943            Impact factor:   18.561


  59 in total

Review 1.  Annual Research Review: Discovery science strategies in studies of the pathophysiology of child and adolescent psychiatric disorders--promises and limitations.

Authors:  Yihong Zhao; F Xavier Castellanos
Journal:  J Child Psychol Psychiatry       Date:  2016-01-06       Impact factor: 8.982

Review 2.  Clashing Diagnostic Approaches: DSM-ICD Versus RDoC.

Authors:  Scott O Lilienfeld; Michael T Treadway
Journal:  Annu Rev Clin Psychol       Date:  2016-02-03       Impact factor: 18.561

3.  Influence of maternal depression on children's brooding rumination: Moderation by CRHR1 TAT haplotype.

Authors:  Mary L Woody; Anastacia Y Kudinova; John E McGeary; Valerie S Knopik; Rohan H C Palmer; Brandon E Gibb
Journal:  Cogn Emot       Date:  2015-02-03

4.  Psychometric properties of startle and corrugator response in NPU, affective picture viewing, and resting state tasks.

Authors:  Jesse T Kaye; Daniel E Bradford; John J Curtin
Journal:  Psychophysiology       Date:  2016-05-11       Impact factor: 4.016

5.  Transdiagnostic dimensions of anxiety and depression moderate motivation-related brain networks during goal maintenance.

Authors:  Jeffrey M Spielberg; Gregory A Miller; Stacie L Warren; Bradley P Sutton; Marie Banich; Wendy Heller
Journal:  Depress Anxiety       Date:  2014-04-17       Impact factor: 6.505

6.  Methodological issues in the use of individual brain measures to index trait liabilities: The example of noise-probe P3.

Authors:  Emily R Perkins; James R Yancey; Laura E Drislane; Noah C Venables; Steve Balsis; Christopher J Patrick
Journal:  Int J Psychophysiol       Date:  2016-11-14       Impact factor: 2.997

7.  Electrophysiological Endophenotypes and the Error-Related Negativity (ERN) in Autism Spectrum Disorder: A Family Study.

Authors:  Ann Clawson; Mikle South; Scott A Baldwin; Michael J Larson
Journal:  J Autism Dev Disord       Date:  2017-05

Review 8.  Molecular genetic approaches to understanding the comorbidity of psychiatric disorders.

Authors:  Ian R Gizer
Journal:  Dev Psychopathol       Date:  2016-11

Review 9.  Electrophysiological Endophenotypes for Schizophrenia.

Authors:  Emily M Owens; Peter Bachman; David C Glahn; Carrie E Bearden
Journal:  Harv Rev Psychiatry       Date:  2016 Mar-Apr       Impact factor: 3.732

Review 10.  Arguments for the sake of endophenotypes: examining common misconceptions about the use of endophenotypes in psychiatric genetics.

Authors:  David C Glahn; Emma E M Knowles; D Reese McKay; Emma Sprooten; Henriette Raventós; John Blangero; Irving I Gottesman; Laura Almasy
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2014-01-24       Impact factor: 3.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.